Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study	Advanced Hodgkin Lymphoma	Active, not recruiting	Phase 2	2026-09-11		NCT03517137

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
European Organisation for Research and Treatment of Cancer - EORTC	54

16 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Amsterdam UMC - Locatie AMC	Amsterdam	Netherlands	1
Complejo Hospitalario de Navarra	Pamplona	Spain	10
Deventer Ziekenhuis	Deventer	Netherlands	1
Erasmus MC	Rotterdam	Netherlands	8
Haaglanden Medisch Centrum (HMC) - Haaglanden MC - locatie Antoniushove	Leidschendam	Netherlands	1
Hospital Duran i Reynals (Institut Catala D'Oncologia)	L'Hospitalet de Llobregat	Spain	1
Instituto Portugues De Oncologia - Francisco Gentil - Centro De Lisboa	Lisbon	Portugal	1
Maria Sklodowska Curie National Institute of Oncology - National Research Institute	Warsaw	Poland	1
Medisch Centrum Leeuwarden-Zuid	Leeuwarden	Netherlands	1
National Cancer Institute	Bratislava	Slovakia	1
Radboudumc - Radboud University Medical Center Nijmegen	Nijmegen	Netherlands	3
U.Z. Leuven - Campus Gasthuisberg	Leuven	Belgium	5
Universitair Ziekenhuis Antwerpen	Edegem	Belgium	46
University Hospitals Copenhagen - Rigshospitalet	Copenhagen	Denmark	3
University Medical Center Groningen	Groningen	Netherlands	7
ZNA Stuivenberg	Antwerp	Belgium	5